Glycaemic control and self-management behaviours in Type 2 diabetes: Results from a 1-year longitudinal cohort study

Diabetic Medicine

Volumn 32, Issue 9, 2015, Pages 1247-1254

  Houle, Janie ^a,b   Beaulieu, M D ^b   Chiasson, J L ^b   Lesperance F ^b   Cote J ^b   Strychar, I ^b   Bherer, L ^c,d   Meunier, S ^a   Lambert, J ^b  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Dept of Electrical and Computer Engineering   (Canada)

^d CENTRE DE RECHERCHE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; BLOOD GLUCOSE MONITORING; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION ANALYSIS; DEMOGRAPHY; DIET; DRUG USE; EDUCATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; POVERTY; PROSPECTIVE STUDY; SELF CARE; SELF MONITORING; SOCIOECONOMICS; STATISTICAL ANALYSIS; SUMMARY OF DIABETES SELF CARE ACITIVITIES; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; KINESIOTHERAPY; MEDICATION COMPLIANCE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RISK REDUCTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE THERAPY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; SELF CARE; SOCIOECONOMIC FACTORS;

EID: 84939268947     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12686     Document Type: Article

References (30)

1. Stolar M. Glycemic control and complications in type 2 diabetes mellitus. Am J Med 2010; 123: S3-S11.
2. Vasudevan AR, Burns A, Fonseca VA. The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus. Treat Endocrinol 2006; 5: 273-286.
3. Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 and type 2 diabetes mellitus. J Manag Care Pharm 2010; 16: 264-275.
4. Deakin T, McShane CE, Cade JE, Williams RD. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005, 2, CD003417.
5. Dirmaier J, Watzke B, Koch U, Schulz H, Lehnert H, Peiper L, Wittchen HU. Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control. Psychother Psychosom 2010; 79: 172-178.
6. Aikens JE, Piette JD. Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes. Diabet Med 2013; 30: 338-344.
7. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Di Nardo B, Greenfield S et al. Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med 2005; 22: 900-906.
8. Toobert DJ, Hampson SE, Glasgow RE. The Summary of Diabetes Self-Care Activities Measure. Results from 7 studies and a revised Scale. Diabetes Care 2000; 23: 943-950.
9. Majumbar SR, Johnson JA, Bowker SL, Booth GL. A Canadian consensus for the standardized evaluation of quality improvement interventions in Type 2 diabetes. Can J Diabetes 2005; 29: 220-229.
10. Mayberry LS, Gonzalez JS, Wallston KA, Kripalani S, Osborn CY. The ARMS-D out performs the SDSCA, but both are reliable, valid and predict glycemic control. Diabetes Res Clin Pract 2013; 102: 96-104.
11. Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index withphysicalfunction as the outcome. J Clin Epid 2005; 58: 595-602.
12. Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D. The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002; 17: 1-16.
13. Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of PRIME-MD. The PHQ Primary Care Study. JAMA 1999; 282: 1737-1744.
14. Franz MJ, Boucher JL, Evert AB. Evidence-based diabetes nutrition therapy recommendations are effective: the key if individualization. Diabetes Metab Syndr Obes 2014; 7: 65-72.
15. Kulkarni K. Diets do not fail: the success of medical nutrition therapy in patients with diabetes. Endocr Pract 2006; 12: 121-123.
16. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2014; 37: S120-S143.
17. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; 19: CD002968.
18. Duclos M, Oppert JM, Verges B, Coliche V, Gauthier JF, Guezennec Y et al. SFD Diabetes and physical activity working group. Physical activity and type 2 diabetes: Recommandations of the SFD (Francophone Diabetes Society) diabetes and physical activity working group. Diabetes Metab 2013; 39: 205-216.
19. Speight J, Browne JL, Furler J. Challenging evidence and assumptions: is there a role for self-monitoring of blood glucose in people with type 2 diabetes not using insulin? Curr Med Res Opin 2013; 29: 161-168.
20. Polonsky WH, Fisher L. Self-monitoring of blood glucose in noninsulin-using Type 2 diabetic patients: right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for noninsulin users. Diabetes Care 2013; 36: 179-182.
21. Malanda UL, Bot SD, Nijpels G. Self-monitoring of blood glucose in noninsulin-using Type 2 diabetic patients: it is time to face the evidence. Diabetes Care 2013; 36: 176-178.
22. Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev 2012; 1: CD005060.
23. Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton AM et al. Self-monitoring of blood glucose in Type 2 diabetes: recent studies. J Diabetes Sci Technol 2013; 7: 478.
24. INESS. Self-monitoring of blood glucose in adults with type 2 diabetes not treated with insulin. Québec: 2013. Available at http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/MaladiesChroniques/INESSS_Guide_usage_EN_ASG.pdf Last accessed 22 July 2014.
25. Polonsky WH, Fisher L, Hessler D, Edelman SV. What is so tough about self-monitoring of blood glucose? Perceived obstacles among patients with Type 2 diabetes. Diabet Med 2014; 31: 40-46.
26. Doggrell SA, Warot S. The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. Int J Clin Pharm 2014; 36: 488-497.
27. Kurlander JE, Kerr EA, Krein S, Heisler M, Piette JD. Cost-related nonadherence to medications among patients with diabetes and chornic pain: factors beyond finances. Diabetes Care 2009; 32: 2143-2148.
28. Bailey GR, Barner JC, Weems JK, Leckbee G, Solis R, Montemayor D et al. Assessing barriers to medication adherence in underserved patients with diabetes in Texas. Diabetes Educ 2012; 38: 271-279.
29. Glazier RH, Bajcar J, Kennie NR, Willson K. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care 2006; 29: 1675-1688.
30. Grintsova O, Maier W, Mielck A. Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review. Int J Equity Health 2014; 13: 43.